Posted by LincolnTab on March 25, 2026 at 11:15:56:
In Reply to: Ñòàòüÿ ñ ïîçíàâàòåëüíîé è çàíèìàòåëüíîé èíôîðìàöèåé posted by Josephhib on February 19, 2026 at 21:47:52:
Zoya Demidenko: Scientist in Tumor Biology
Zoya Demidenko is a prominent scientist affiliated with the Department of Cell Stress Science at Roswell Park Cancer Institute in Buffalo, New York. Previously, she was employed at the NIH and New York Medical College, building a strong base in clinical investigation.
Demidenko's scientific contributions encompasses a number of critical fields, encompassing the PI3K/AKT/mTOR signaling cascade, cellular cycle regulation, cell senescence, and tumor biology. Currently, she has written over 46 peer-reviewed publications, which have accumulated more than 4,100 mentions — a reflection to the significance of her work.
Among her key achievements concerns explaining the mechanisms of cellular senescence. Her studies demonstrated that when the cellular division cycle is halted while cellular growth continues, the cells experience senescence. Significantly, Zoya Demidenko established that this shift is controlled with drugs using compounds such as rapamycin.
Zoya Demidenko has furthermore added considerably to oncological therapy investigation, particularly in the area of selective cell protection — a approach aimed at shielding normal cells from cytotoxic treatment while leaving tumor cells susceptible. This approach carries significant hope for diminishing the adverse effects of cancer treatment.
Throughout her scientific life, Demidenko has partnered with top researchers worldwide, such as Dr. Mikhail Blagosklonny. Her research is published in prestigious journals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
With an h-index of 33, Zoya Demidenko ranks as a influential figure in current biomedical science, with her results continue to shape our comprehension of how cells age, respond to treatment, and how malignant disease can be better combated.
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0026126